nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—CA9—kidney cancer	0.477	0.78	CbGaD
Bumetanide—PTGS2—kidney cancer	0.134	0.22	CbGaD
Bumetanide—SLC12A1—collecting duct of renal tubule—kidney cancer	0.0175	0.167	CbGeAlD
Bumetanide—SLC12A1—nephron—kidney cancer	0.00777	0.0743	CbGeAlD
Bumetanide—SLC12A1—urine—kidney cancer	0.00623	0.0596	CbGeAlD
Bumetanide—SLC22A8—nephron—kidney cancer	0.00451	0.0431	CbGeAlD
Bumetanide—SLC22A8—urine—kidney cancer	0.00362	0.0346	CbGeAlD
Bumetanide—PTGS2—nephron—kidney cancer	0.00256	0.0245	CbGeAlD
Bumetanide—SLC12A4—gonad—kidney cancer	0.00236	0.0226	CbGeAlD
Bumetanide—CFTR—renal system—kidney cancer	0.00207	0.0198	CbGeAlD
Bumetanide—CA7—renal system—kidney cancer	0.00204	0.0195	CbGeAlD
Bumetanide—CFTR—kidney—kidney cancer	0.002	0.0191	CbGeAlD
Bumetanide—SLC12A2—nephron tubule—kidney cancer	0.002	0.0191	CbGeAlD
Bumetanide—CA7—kidney—kidney cancer	0.00197	0.0188	CbGeAlD
Bumetanide—SLC12A2—renal system—kidney cancer	0.00182	0.0174	CbGeAlD
Bumetanide—SLC12A2—kidney—kidney cancer	0.00176	0.0168	CbGeAlD
Bumetanide—SLC22A11—nephron tubule—kidney cancer	0.00173	0.0165	CbGeAlD
Bumetanide—SLC10A1—renal system—kidney cancer	0.00172	0.0164	CbGeAlD
Bumetanide—SLC12A2—cortex of kidney—kidney cancer	0.00171	0.0164	CbGeAlD
Bumetanide—SLC12A1—nephron tubule—kidney cancer	0.00168	0.016	CbGeAlD
Bumetanide—SLC10A1—kidney—kidney cancer	0.00166	0.0159	CbGeAlD
Bumetanide—SLC12A2—gonad—kidney cancer	0.00163	0.0156	CbGeAlD
Bumetanide—SLC12A2—cardiac atrium—kidney cancer	0.00163	0.0156	CbGeAlD
Bumetanide—SLC22A6—nephron tubule—kidney cancer	0.00163	0.0156	CbGeAlD
Bumetanide—SLC22A11—renal system—kidney cancer	0.00157	0.015	CbGeAlD
Bumetanide—Furosemide—CA9—kidney cancer	0.00155	0.244	CrCbGaD
Bumetanide—SLC10A1—gonad—kidney cancer	0.00154	0.0147	CbGeAlD
Bumetanide—SLC22A7—renal system—kidney cancer	0.00153	0.0146	CbGeAlD
Bumetanide—SLC12A1—renal system—kidney cancer	0.00152	0.0146	CbGeAlD
Bumetanide—CA14—cardiac atrium—kidney cancer	0.00152	0.0145	CbGeAlD
Bumetanide—SLC22A11—kidney—kidney cancer	0.00152	0.0145	CbGeAlD
Bumetanide—SLC22A7—kidney—kidney cancer	0.00148	0.0142	CbGeAlD
Bumetanide—SLC22A11—cortex of kidney—kidney cancer	0.00148	0.0141	CbGeAlD
Bumetanide—SLC12A1—kidney—kidney cancer	0.00147	0.0141	CbGeAlD
Bumetanide—SLC22A7—cortex of kidney—kidney cancer	0.00144	0.0138	CbGeAlD
Bumetanide—SLC12A1—cortex of kidney—kidney cancer	0.00144	0.0137	CbGeAlD
Bumetanide—Furosemide—CA2—kidney cancer	0.0014	0.22	CrCbGaD
Bumetanide—SLC22A6—cortex of kidney—kidney cancer	0.00139	0.0133	CbGeAlD
Bumetanide—Indapamide—CA9—kidney cancer	0.00134	0.211	CrCbGaD
Bumetanide—CA12—renal system—kidney cancer	0.00132	0.0127	CbGeAlD
Bumetanide—CA12—kidney—kidney cancer	0.00128	0.0122	CbGeAlD
Bumetanide—Indapamide—CA2—kidney cancer	0.0012	0.189	CrCbGaD
Bumetanide—CA5B—gonad—kidney cancer	0.00107	0.0102	CbGeAlD
Bumetanide—CA5B—cardiac atrium—kidney cancer	0.00106	0.0102	CbGeAlD
Bumetanide—SLC22A8—nephron tubule—kidney cancer	0.000974	0.00931	CbGeAlD
Bumetanide—SLCO1A2—renal system—kidney cancer	0.000927	0.00887	CbGeAlD
Bumetanide—CA4—nephron tubule—kidney cancer	0.000902	0.00863	CbGeAlD
Bumetanide—SLCO1A2—kidney—kidney cancer	0.000896	0.00857	CbGeAlD
Bumetanide—SLC22A8—renal system—kidney cancer	0.000885	0.00846	CbGeAlD
Bumetanide—SLC22A8—kidney—kidney cancer	0.000856	0.00818	CbGeAlD
Bumetanide—SLC22A8—cortex of kidney—kidney cancer	0.000833	0.00797	CbGeAlD
Bumetanide—CA4—renal system—kidney cancer	0.00082	0.00784	CbGeAlD
Bumetanide—CA4—kidney—kidney cancer	0.000793	0.00758	CbGeAlD
Bumetanide—CA4—cortex of kidney—kidney cancer	0.000772	0.00738	CbGeAlD
Bumetanide—CA4—cardiac atrium—kidney cancer	0.000735	0.00702	CbGeAlD
Bumetanide—Fenoprofen—PTGS1—kidney cancer	0.00055	0.0865	CrCbGaD
Bumetanide—PTGS2—renal system—kidney cancer	0.000502	0.0048	CbGeAlD
Bumetanide—PTGS2—kidney—kidney cancer	0.000485	0.00464	CbGeAlD
Bumetanide—Hyperglycaemia—Gemcitabine—kidney cancer	0.000422	0.00272	CcSEcCtD
Bumetanide—Abdominal pain—Temsirolimus—kidney cancer	0.000421	0.00272	CcSEcCtD
Bumetanide—Sweating—Vincristine—kidney cancer	0.000421	0.00272	CcSEcCtD
Bumetanide—Dehydration—Paclitaxel—kidney cancer	0.000421	0.00272	CcSEcCtD
Bumetanide—Erythema multiforme—Dactinomycin—kidney cancer	0.000417	0.00269	CcSEcCtD
Bumetanide—Arthralgia—Everolimus—kidney cancer	0.000414	0.00267	CcSEcCtD
Bumetanide—Chest pain—Everolimus—kidney cancer	0.000414	0.00267	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.000413	0.00267	CcSEcCtD
Bumetanide—Hypokalaemia—Paclitaxel—kidney cancer	0.000412	0.00266	CcSEcCtD
Bumetanide—Gastrointestinal pain—Pazopanib—kidney cancer	0.000411	0.00265	CcSEcCtD
Bumetanide—Renal failure—Gemcitabine—kidney cancer	0.00041	0.00264	CcSEcCtD
Bumetanide—Cramp muscle—Paclitaxel—kidney cancer	0.000408	0.00263	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.000408	0.00263	CcSEcCtD
Bumetanide—Glycosuria—Doxorubicin—kidney cancer	0.000407	0.00263	CcSEcCtD
Bumetanide—Muscle spasms—Sorafenib—kidney cancer	0.000405	0.00262	CcSEcCtD
Bumetanide—Dry mouth—Everolimus—kidney cancer	0.000405	0.00261	CcSEcCtD
Bumetanide—Sweating—Gemcitabine—kidney cancer	0.000399	0.00258	CcSEcCtD
Bumetanide—Arthralgia—Erlotinib—kidney cancer	0.000399	0.00258	CcSEcCtD
Bumetanide—Chest pain—Erlotinib—kidney cancer	0.000399	0.00258	CcSEcCtD
Bumetanide—Abdominal pain—Pazopanib—kidney cancer	0.000397	0.00256	CcSEcCtD
Bumetanide—Blood disorder—Doxorubicin—kidney cancer	0.000395	0.00255	CcSEcCtD
Bumetanide—Liver injury—Doxorubicin—kidney cancer	0.000392	0.00253	CcSEcCtD
Bumetanide—Muscle spasms—Sunitinib—kidney cancer	0.00039	0.00252	CcSEcCtD
Bumetanide—Thrombocytopenia—Vinblastine—kidney cancer	0.00039	0.00252	CcSEcCtD
Bumetanide—Thrombocytopenia—Everolimus—kidney cancer	0.000388	0.00251	CcSEcCtD
Bumetanide—Pancreatitis—Paclitaxel—kidney cancer	0.000384	0.00248	CcSEcCtD
Bumetanide—Hyperhidrosis—Everolimus—kidney cancer	0.000383	0.00247	CcSEcCtD
Bumetanide—Asthenia—Temsirolimus—kidney cancer	0.000382	0.00247	CcSEcCtD
Bumetanide—Leukopenia—Sorafenib—kidney cancer	0.000378	0.00244	CcSEcCtD
Bumetanide—Pruritus—Temsirolimus—kidney cancer	0.000377	0.00243	CcSEcCtD
Bumetanide—Thrombocytopenia—Erlotinib—kidney cancer	0.000375	0.00242	CcSEcCtD
Bumetanide—Hyponatraemia—Capecitabine—kidney cancer	0.000373	0.00241	CcSEcCtD
Bumetanide—Hypotension—Everolimus—kidney cancer	0.000371	0.00239	CcSEcCtD
Bumetanide—Diarrhoea—Temsirolimus—kidney cancer	0.000365	0.00235	CcSEcCtD
Bumetanide—Leukopenia—Sunitinib—kidney cancer	0.000363	0.00234	CcSEcCtD
Bumetanide—Asthenia—Pazopanib—kidney cancer	0.00036	0.00233	CcSEcCtD
Bumetanide—Arthralgia—Sorafenib—kidney cancer	0.000359	0.00232	CcSEcCtD
Bumetanide—Hyperuricaemia—Doxorubicin—kidney cancer	0.000356	0.0023	CcSEcCtD
Bumetanide—Pruritus—Pazopanib—kidney cancer	0.000355	0.00229	CcSEcCtD
Bumetanide—Erythema multiforme—Gemcitabine—kidney cancer	0.000354	0.00228	CcSEcCtD
Bumetanide—Hyperglycaemia—Paclitaxel—kidney cancer	0.000353	0.00228	CcSEcCtD
Bumetanide—Dizziness—Temsirolimus—kidney cancer	0.000352	0.00228	CcSEcCtD
Bumetanide—Dry mouth—Sorafenib—kidney cancer	0.000351	0.00227	CcSEcCtD
Bumetanide—Blood creatinine increased—Capecitabine—kidney cancer	0.000348	0.00225	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000346	0.00223	CcSEcCtD
Bumetanide—Arthralgia—Sunitinib—kidney cancer	0.000345	0.00223	CcSEcCtD
Bumetanide—Chest pain—Sunitinib—kidney cancer	0.000345	0.00223	CcSEcCtD
Bumetanide—Dehydration—Capecitabine—kidney cancer	0.000345	0.00223	CcSEcCtD
Bumetanide—Leukopenia—Dactinomycin—kidney cancer	0.000344	0.00222	CcSEcCtD
Bumetanide—Diarrhoea—Pazopanib—kidney cancer	0.000344	0.00222	CcSEcCtD
Bumetanide—Renal failure—Paclitaxel—kidney cancer	0.000343	0.00221	CcSEcCtD
Bumetanide—Fatigue—Everolimus—kidney cancer	0.000342	0.00221	CcSEcCtD
Bumetanide—Vomiting—Temsirolimus—kidney cancer	0.000339	0.00219	CcSEcCtD
Bumetanide—Hypokalaemia—Capecitabine—kidney cancer	0.000338	0.00218	CcSEcCtD
Bumetanide—Dry mouth—Sunitinib—kidney cancer	0.000338	0.00218	CcSEcCtD
Bumetanide—Thrombocytopenia—Sorafenib—kidney cancer	0.000337	0.00217	CcSEcCtD
Bumetanide—Rash—Temsirolimus—kidney cancer	0.000336	0.00217	CcSEcCtD
Bumetanide—Blood uric acid increased—Doxorubicin—kidney cancer	0.000336	0.00217	CcSEcCtD
Bumetanide—Dermatitis—Temsirolimus—kidney cancer	0.000336	0.00217	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.000335	0.00216	CcSEcCtD
Bumetanide—Headache—Temsirolimus—kidney cancer	0.000334	0.00216	CcSEcCtD
Bumetanide—Musculoskeletal pain—Doxorubicin—kidney cancer	0.000334	0.00215	CcSEcCtD
Bumetanide—Dizziness—Pazopanib—kidney cancer	0.000332	0.00214	CcSEcCtD
Bumetanide—Hepatocellular injury—Doxorubicin—kidney cancer	0.00033	0.00213	CcSEcCtD
Bumetanide—Fatigue—Erlotinib—kidney cancer	0.00033	0.00213	CcSEcCtD
Bumetanide—Gastrointestinal pain—Vinblastine—kidney cancer	0.000325	0.0021	CcSEcCtD
Bumetanide—Thrombocytopenia—Sunitinib—kidney cancer	0.000324	0.00209	CcSEcCtD
Bumetanide—Gastrointestinal pain—Everolimus—kidney cancer	0.000324	0.00209	CcSEcCtD
Bumetanide—Vomiting—Pazopanib—kidney cancer	0.000319	0.00206	CcSEcCtD
Bumetanide—Rash—Pazopanib—kidney cancer	0.000317	0.00204	CcSEcCtD
Bumetanide—Nausea—Temsirolimus—kidney cancer	0.000317	0.00204	CcSEcCtD
Bumetanide—Dermatitis—Pazopanib—kidney cancer	0.000316	0.00204	CcSEcCtD
Bumetanide—Abdominal pain—Vinblastine—kidney cancer	0.000315	0.00203	CcSEcCtD
Bumetanide—Headache—Pazopanib—kidney cancer	0.000315	0.00203	CcSEcCtD
Bumetanide—Fenoprofen—PTGS2—kidney cancer	0.000314	0.0495	CrCbGaD
Bumetanide—Abdominal pain—Everolimus—kidney cancer	0.000313	0.00202	CcSEcCtD
Bumetanide—Gastrointestinal pain—Erlotinib—kidney cancer	0.000313	0.00202	CcSEcCtD
Bumetanide—Vertigo—Vincristine—kidney cancer	0.000308	0.00199	CcSEcCtD
Bumetanide—Abdominal discomfort—Capecitabine—kidney cancer	0.000308	0.00199	CcSEcCtD
Bumetanide—Leukopenia—Vincristine—kidney cancer	0.000307	0.00198	CcSEcCtD
Bumetanide—Thrombocytopenia—Dactinomycin—kidney cancer	0.000307	0.00198	CcSEcCtD
Bumetanide—Abdominal pain—Erlotinib—kidney cancer	0.000302	0.00195	CcSEcCtD
Bumetanide—Nausea—Pazopanib—kidney cancer	0.000298	0.00193	CcSEcCtD
Bumetanide—Fatigue—Sorafenib—kidney cancer	0.000297	0.00192	CcSEcCtD
Bumetanide—Erythema multiforme—Paclitaxel—kidney cancer	0.000296	0.00191	CcSEcCtD
Bumetanide—Leukopenia—Gemcitabine—kidney cancer	0.000291	0.00188	CcSEcCtD
Bumetanide—Hyperglycaemia—Capecitabine—kidney cancer	0.00029	0.00187	CcSEcCtD
Bumetanide—Asthenia—Vinblastine—kidney cancer	0.000286	0.00184	CcSEcCtD
Bumetanide—Fatigue—Sunitinib—kidney cancer	0.000286	0.00184	CcSEcCtD
Bumetanide—Asthenia—Everolimus—kidney cancer	0.000284	0.00184	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000284	0.00183	CcSEcCtD
Bumetanide—Gastrointestinal pain—Sorafenib—kidney cancer	0.000281	0.00182	CcSEcCtD
Bumetanide—Renal failure—Capecitabine—kidney cancer	0.000281	0.00182	CcSEcCtD
Bumetanide—Pruritus—Everolimus—kidney cancer	0.000281	0.00181	CcSEcCtD
Bumetanide—Arthralgia—Gemcitabine—kidney cancer	0.000277	0.00179	CcSEcCtD
Bumetanide—Chest pain—Gemcitabine—kidney cancer	0.000277	0.00179	CcSEcCtD
Bumetanide—Asthenia—Erlotinib—kidney cancer	0.000274	0.00177	CcSEcCtD
Bumetanide—Thrombocytopenia—Vincristine—kidney cancer	0.000274	0.00177	CcSEcCtD
Bumetanide—Urticaria—Sorafenib—kidney cancer	0.000273	0.00176	CcSEcCtD
Bumetanide—Diarrhoea—Vinblastine—kidney cancer	0.000272	0.00176	CcSEcCtD
Bumetanide—Abdominal pain—Sorafenib—kidney cancer	0.000272	0.00176	CcSEcCtD
Bumetanide—Diarrhoea—Everolimus—kidney cancer	0.000271	0.00175	CcSEcCtD
Bumetanide—Gastrointestinal pain—Sunitinib—kidney cancer	0.000271	0.00175	CcSEcCtD
Bumetanide—Hyperhidrosis—Vincristine—kidney cancer	0.000271	0.00175	CcSEcCtD
Bumetanide—Pruritus—Erlotinib—kidney cancer	0.000271	0.00175	CcSEcCtD
Bumetanide—Fatigue—Dactinomycin—kidney cancer	0.00027	0.00174	CcSEcCtD
Bumetanide—Dizziness—Vinblastine—kidney cancer	0.000263	0.0017	CcSEcCtD
Bumetanide—Dizziness—Everolimus—kidney cancer	0.000262	0.00169	CcSEcCtD
Bumetanide—Muscle spasms—Paclitaxel—kidney cancer	0.000262	0.00169	CcSEcCtD
Bumetanide—Abdominal pain—Sunitinib—kidney cancer	0.000262	0.00169	CcSEcCtD
Bumetanide—Diarrhoea—Erlotinib—kidney cancer	0.000262	0.00169	CcSEcCtD
Bumetanide—Hypotension—Vincristine—kidney cancer	0.000262	0.00169	CcSEcCtD
Bumetanide—Thrombocytopenia—Gemcitabine—kidney cancer	0.00026	0.00168	CcSEcCtD
Bumetanide—Hyperhidrosis—Gemcitabine—kidney cancer	0.000257	0.00166	CcSEcCtD
Bumetanide—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000256	0.00165	CcSEcCtD
Bumetanide—Vomiting—Vinblastine—kidney cancer	0.000253	0.00163	CcSEcCtD
Bumetanide—Dizziness—Erlotinib—kidney cancer	0.000253	0.00163	CcSEcCtD
Bumetanide—Vomiting—Everolimus—kidney cancer	0.000252	0.00163	CcSEcCtD
Bumetanide—Rash—Everolimus—kidney cancer	0.00025	0.00161	CcSEcCtD
Bumetanide—Dermatitis—Everolimus—kidney cancer	0.00025	0.00161	CcSEcCtD
Bumetanide—Headache—Vinblastine—kidney cancer	0.000249	0.00161	CcSEcCtD
Bumetanide—Headache—Everolimus—kidney cancer	0.000248	0.0016	CcSEcCtD
Bumetanide—Hypotension—Gemcitabine—kidney cancer	0.000248	0.0016	CcSEcCtD
Bumetanide—Abdominal pain—Dactinomycin—kidney cancer	0.000248	0.0016	CcSEcCtD
Bumetanide—Asthenia—Sorafenib—kidney cancer	0.000247	0.00159	CcSEcCtD
Bumetanide—Vertigo—Paclitaxel—kidney cancer	0.000245	0.00158	CcSEcCtD
Bumetanide—Leukopenia—Paclitaxel—kidney cancer	0.000244	0.00157	CcSEcCtD
Bumetanide—Pruritus—Sorafenib—kidney cancer	0.000244	0.00157	CcSEcCtD
Bumetanide—Vomiting—Erlotinib—kidney cancer	0.000243	0.00157	CcSEcCtD
Bumetanide—Erythema multiforme—Capecitabine—kidney cancer	0.000243	0.00157	CcSEcCtD
Bumetanide—Fatigue—Vincristine—kidney cancer	0.000242	0.00156	CcSEcCtD
Bumetanide—Rash—Erlotinib—kidney cancer	0.000241	0.00156	CcSEcCtD
Bumetanide—Dermatitis—Erlotinib—kidney cancer	0.000241	0.00156	CcSEcCtD
Bumetanide—Hyponatraemia—Doxorubicin—kidney cancer	0.00024	0.00155	CcSEcCtD
Bumetanide—Headache—Erlotinib—kidney cancer	0.00024	0.00155	CcSEcCtD
Bumetanide—Asthenia—Sunitinib—kidney cancer	0.000238	0.00153	CcSEcCtD
Bumetanide—Nausea—Vinblastine—kidney cancer	0.000236	0.00153	CcSEcCtD
Bumetanide—Nausea—Everolimus—kidney cancer	0.000236	0.00152	CcSEcCtD
Bumetanide—Diarrhoea—Sorafenib—kidney cancer	0.000235	0.00152	CcSEcCtD
Bumetanide—Pruritus—Sunitinib—kidney cancer	0.000234	0.00151	CcSEcCtD
Bumetanide—Arthralgia—Paclitaxel—kidney cancer	0.000232	0.0015	CcSEcCtD
Bumetanide—Chest pain—Paclitaxel—kidney cancer	0.000232	0.0015	CcSEcCtD
Bumetanide—Fatigue—Gemcitabine—kidney cancer	0.000229	0.00148	CcSEcCtD
Bumetanide—Gastrointestinal pain—Vincristine—kidney cancer	0.000229	0.00148	CcSEcCtD
Bumetanide—Dizziness—Sorafenib—kidney cancer	0.000228	0.00147	CcSEcCtD
Bumetanide—Nausea—Erlotinib—kidney cancer	0.000227	0.00147	CcSEcCtD
Bumetanide—Dry mouth—Paclitaxel—kidney cancer	0.000227	0.00146	CcSEcCtD
Bumetanide—Diarrhoea—Sunitinib—kidney cancer	0.000227	0.00146	CcSEcCtD
Bumetanide—Asthenia—Dactinomycin—kidney cancer	0.000225	0.00145	CcSEcCtD
Bumetanide—Blood creatinine increased—Doxorubicin—kidney cancer	0.000224	0.00145	CcSEcCtD
Bumetanide—Dehydration—Doxorubicin—kidney cancer	0.000223	0.00144	CcSEcCtD
Bumetanide—Abdominal pain—Vincristine—kidney cancer	0.000221	0.00143	CcSEcCtD
Bumetanide—Dizziness—Sunitinib—kidney cancer	0.000219	0.00141	CcSEcCtD
Bumetanide—Vomiting—Sorafenib—kidney cancer	0.000219	0.00141	CcSEcCtD
Bumetanide—Hypokalaemia—Doxorubicin—kidney cancer	0.000218	0.00141	CcSEcCtD
Bumetanide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000218	0.00141	CcSEcCtD
Bumetanide—Rash—Sorafenib—kidney cancer	0.000217	0.0014	CcSEcCtD
Bumetanide—Dermatitis—Sorafenib—kidney cancer	0.000217	0.0014	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000216	0.00139	CcSEcCtD
Bumetanide—Headache—Sorafenib—kidney cancer	0.000216	0.00139	CcSEcCtD
Bumetanide—Muscle spasms—Capecitabine—kidney cancer	0.000215	0.00139	CcSEcCtD
Bumetanide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000215	0.00139	CcSEcCtD
Bumetanide—Diarrhoea—Dactinomycin—kidney cancer	0.000215	0.00138	CcSEcCtD
Bumetanide—Vomiting—Sunitinib—kidney cancer	0.000211	0.00136	CcSEcCtD
Bumetanide—Rash—Sunitinib—kidney cancer	0.000209	0.00135	CcSEcCtD
Bumetanide—Dermatitis—Sunitinib—kidney cancer	0.000209	0.00135	CcSEcCtD
Bumetanide—Hypotension—Paclitaxel—kidney cancer	0.000208	0.00134	CcSEcCtD
Bumetanide—Headache—Sunitinib—kidney cancer	0.000207	0.00134	CcSEcCtD
Bumetanide—Nausea—Sorafenib—kidney cancer	0.000204	0.00132	CcSEcCtD
Bumetanide—Pancreatitis—Doxorubicin—kidney cancer	0.000203	0.00131	CcSEcCtD
Bumetanide—Vertigo—Capecitabine—kidney cancer	0.000201	0.0013	CcSEcCtD
Bumetanide—Asthenia—Vincristine—kidney cancer	0.000201	0.0013	CcSEcCtD
Bumetanide—Leukopenia—Capecitabine—kidney cancer	0.0002	0.00129	CcSEcCtD
Bumetanide—Vomiting—Dactinomycin—kidney cancer	0.000199	0.00129	CcSEcCtD
Bumetanide—Rash—Dactinomycin—kidney cancer	0.000198	0.00128	CcSEcCtD
Bumetanide—Nausea—Sunitinib—kidney cancer	0.000197	0.00127	CcSEcCtD
Bumetanide—Fatigue—Paclitaxel—kidney cancer	0.000192	0.00124	CcSEcCtD
Bumetanide—Diarrhoea—Vincristine—kidney cancer	0.000192	0.00124	CcSEcCtD
Bumetanide—Asthenia—Gemcitabine—kidney cancer	0.000191	0.00123	CcSEcCtD
Bumetanide—Chest pain—Capecitabine—kidney cancer	0.00019	0.00123	CcSEcCtD
Bumetanide—Arthralgia—Capecitabine—kidney cancer	0.00019	0.00123	CcSEcCtD
Bumetanide—Pruritus—Gemcitabine—kidney cancer	0.000188	0.00121	CcSEcCtD
Bumetanide—Hyperglycaemia—Doxorubicin—kidney cancer	0.000187	0.0012	CcSEcCtD
Bumetanide—Dry mouth—Capecitabine—kidney cancer	0.000186	0.0012	CcSEcCtD
Bumetanide—Nausea—Dactinomycin—kidney cancer	0.000186	0.0012	CcSEcCtD
Bumetanide—Dizziness—Vincristine—kidney cancer	0.000185	0.0012	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000183	0.00118	CcSEcCtD
Bumetanide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000182	0.00117	CcSEcCtD
Bumetanide—Diarrhoea—Gemcitabine—kidney cancer	0.000182	0.00117	CcSEcCtD
Bumetanide—Renal failure—Doxorubicin—kidney cancer	0.000181	0.00117	CcSEcCtD
Bumetanide—Thrombocytopenia—Capecitabine—kidney cancer	0.000179	0.00115	CcSEcCtD
Bumetanide—Vomiting—Vincristine—kidney cancer	0.000178	0.00115	CcSEcCtD
Bumetanide—Sweating—Doxorubicin—kidney cancer	0.000177	0.00114	CcSEcCtD
Bumetanide—Urticaria—Paclitaxel—kidney cancer	0.000177	0.00114	CcSEcCtD
Bumetanide—Rash—Vincristine—kidney cancer	0.000177	0.00114	CcSEcCtD
Bumetanide—Hyperhidrosis—Capecitabine—kidney cancer	0.000177	0.00114	CcSEcCtD
Bumetanide—Dermatitis—Vincristine—kidney cancer	0.000176	0.00114	CcSEcCtD
Bumetanide—Abdominal pain—Paclitaxel—kidney cancer	0.000176	0.00114	CcSEcCtD
Bumetanide—Headache—Vincristine—kidney cancer	0.000175	0.00113	CcSEcCtD
Bumetanide—Hypotension—Capecitabine—kidney cancer	0.000171	0.0011	CcSEcCtD
Bumetanide—Vomiting—Gemcitabine—kidney cancer	0.000169	0.00109	CcSEcCtD
Bumetanide—Rash—Gemcitabine—kidney cancer	0.000168	0.00108	CcSEcCtD
Bumetanide—Dermatitis—Gemcitabine—kidney cancer	0.000167	0.00108	CcSEcCtD
Bumetanide—Headache—Gemcitabine—kidney cancer	0.000166	0.00107	CcSEcCtD
Bumetanide—Nausea—Vincristine—kidney cancer	0.000166	0.00107	CcSEcCtD
Bumetanide—Asthenia—Paclitaxel—kidney cancer	0.00016	0.00103	CcSEcCtD
Bumetanide—Nausea—Gemcitabine—kidney cancer	0.000158	0.00102	CcSEcCtD
Bumetanide—Fatigue—Capecitabine—kidney cancer	0.000157	0.00102	CcSEcCtD
Bumetanide—Pruritus—Paclitaxel—kidney cancer	0.000157	0.00102	CcSEcCtD
Bumetanide—Erythema multiforme—Doxorubicin—kidney cancer	0.000157	0.00101	CcSEcCtD
Bumetanide—Diarrhoea—Paclitaxel—kidney cancer	0.000152	0.000983	CcSEcCtD
Bumetanide—Gastrointestinal pain—Capecitabine—kidney cancer	0.000149	0.000964	CcSEcCtD
Bumetanide—Dizziness—Paclitaxel—kidney cancer	0.000147	0.00095	CcSEcCtD
Bumetanide—Urticaria—Capecitabine—kidney cancer	0.000145	0.000936	CcSEcCtD
Bumetanide—Abdominal pain—Capecitabine—kidney cancer	0.000144	0.000932	CcSEcCtD
Bumetanide—Vomiting—Paclitaxel—kidney cancer	0.000141	0.000913	CcSEcCtD
Bumetanide—Rash—Paclitaxel—kidney cancer	0.00014	0.000905	CcSEcCtD
Bumetanide—Dermatitis—Paclitaxel—kidney cancer	0.00014	0.000905	CcSEcCtD
Bumetanide—Headache—Paclitaxel—kidney cancer	0.000139	0.0009	CcSEcCtD
Bumetanide—Muscle spasms—Doxorubicin—kidney cancer	0.000139	0.000895	CcSEcCtD
Bumetanide—Nausea—Paclitaxel—kidney cancer	0.000132	0.000853	CcSEcCtD
Bumetanide—Asthenia—Capecitabine—kidney cancer	0.000131	0.000845	CcSEcCtD
Bumetanide—Vertigo—Doxorubicin—kidney cancer	0.00013	0.000836	CcSEcCtD
Bumetanide—Pruritus—Capecitabine—kidney cancer	0.000129	0.000834	CcSEcCtD
Bumetanide—Leukopenia—Doxorubicin—kidney cancer	0.000129	0.000833	CcSEcCtD
Bumetanide—Diarrhoea—Capecitabine—kidney cancer	0.000125	0.000806	CcSEcCtD
Bumetanide—Arthralgia—Doxorubicin—kidney cancer	0.000123	0.000792	CcSEcCtD
Bumetanide—Chest pain—Doxorubicin—kidney cancer	0.000123	0.000792	CcSEcCtD
Bumetanide—Dizziness—Capecitabine—kidney cancer	0.000121	0.000779	CcSEcCtD
Bumetanide—Dry mouth—Doxorubicin—kidney cancer	0.00012	0.000775	CcSEcCtD
Bumetanide—Vomiting—Capecitabine—kidney cancer	0.000116	0.000749	CcSEcCtD
Bumetanide—Thrombocytopenia—Doxorubicin—kidney cancer	0.000115	0.000744	CcSEcCtD
Bumetanide—Rash—Capecitabine—kidney cancer	0.000115	0.000743	CcSEcCtD
Bumetanide—Dermatitis—Capecitabine—kidney cancer	0.000115	0.000742	CcSEcCtD
Bumetanide—Headache—Capecitabine—kidney cancer	0.000114	0.000738	CcSEcCtD
Bumetanide—Hyperhidrosis—Doxorubicin—kidney cancer	0.000114	0.000734	CcSEcCtD
Bumetanide—Hypotension—Doxorubicin—kidney cancer	0.00011	0.00071	CcSEcCtD
Bumetanide—Nausea—Capecitabine—kidney cancer	0.000108	0.0007	CcSEcCtD
Bumetanide—Fatigue—Doxorubicin—kidney cancer	0.000101	0.000655	CcSEcCtD
Bumetanide—Gastrointestinal pain—Doxorubicin—kidney cancer	9.62e-05	0.000621	CcSEcCtD
Bumetanide—Urticaria—Doxorubicin—kidney cancer	9.35e-05	0.000603	CcSEcCtD
Bumetanide—Abdominal pain—Doxorubicin—kidney cancer	9.3e-05	0.0006	CcSEcCtD
Bumetanide—Asthenia—Doxorubicin—kidney cancer	8.44e-05	0.000545	CcSEcCtD
Bumetanide—Pruritus—Doxorubicin—kidney cancer	8.33e-05	0.000537	CcSEcCtD
Bumetanide—Diarrhoea—Doxorubicin—kidney cancer	8.05e-05	0.00052	CcSEcCtD
Bumetanide—Dizziness—Doxorubicin—kidney cancer	7.78e-05	0.000502	CcSEcCtD
Bumetanide—Vomiting—Doxorubicin—kidney cancer	7.48e-05	0.000483	CcSEcCtD
Bumetanide—Rash—Doxorubicin—kidney cancer	7.42e-05	0.000479	CcSEcCtD
Bumetanide—Dermatitis—Doxorubicin—kidney cancer	7.41e-05	0.000479	CcSEcCtD
Bumetanide—Headache—Doxorubicin—kidney cancer	7.37e-05	0.000476	CcSEcCtD
Bumetanide—Nausea—Doxorubicin—kidney cancer	6.99e-05	0.000451	CcSEcCtD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.95e-05	0.000322	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.93e-05	0.000319	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—CCND1—kidney cancer	3.89e-05	0.000316	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GSTT1—kidney cancer	3.88e-05	0.000316	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ACHE—kidney cancer	3.88e-05	0.000316	CbGpPWpGaD
Bumetanide—CA12—Metabolism—SLC2A1—kidney cancer	3.86e-05	0.000314	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—FH—kidney cancer	3.83e-05	0.000311	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APRT—kidney cancer	3.83e-05	0.000311	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GSTP1—kidney cancer	3.82e-05	0.000311	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.82e-05	0.000311	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.75e-05	0.000305	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.74e-05	0.000304	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GSTP1—kidney cancer	3.72e-05	0.000303	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ACHE—kidney cancer	3.71e-05	0.000301	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GSTT1—kidney cancer	3.71e-05	0.000301	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SCARB1—kidney cancer	3.68e-05	0.000299	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTGS1—kidney cancer	3.64e-05	0.000296	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ABCB1—kidney cancer	3.62e-05	0.000294	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GPC3—kidney cancer	3.6e-05	0.000293	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.59e-05	0.000292	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ACY1—kidney cancer	3.59e-05	0.000292	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PSMD7—kidney cancer	3.57e-05	0.00029	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CRABP1—kidney cancer	3.53e-05	0.000287	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ABCB1—kidney cancer	3.53e-05	0.000287	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—VEGFA—kidney cancer	3.52e-05	0.000286	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GSTM1—kidney cancer	3.51e-05	0.000286	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.51e-05	0.000286	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SCARB1—kidney cancer	3.51e-05	0.000285	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CA2—kidney cancer	3.5e-05	0.000285	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GSTP1—kidney cancer	3.48e-05	0.000283	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GSTP1—kidney cancer	3.48e-05	0.000283	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTGS1—kidney cancer	3.47e-05	0.000282	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GSTM1—kidney cancer	3.42e-05	0.000278	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CCBL1—kidney cancer	3.42e-05	0.000278	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALAD—kidney cancer	3.41e-05	0.000277	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PSMD7—kidney cancer	3.41e-05	0.000277	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.39e-05	0.000276	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—BCHE—kidney cancer	3.38e-05	0.000275	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SLC5A5—kidney cancer	3.34e-05	0.000272	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CYP1A1—kidney cancer	3.33e-05	0.000271	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ST3GAL2—kidney cancer	3.33e-05	0.000271	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—MAPK3—kidney cancer	3.33e-05	0.000271	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.3e-05	0.000269	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ABCB1—kidney cancer	3.29e-05	0.000268	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ABCB1—kidney cancer	3.29e-05	0.000268	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ITPR2—kidney cancer	3.28e-05	0.000267	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALDH1A1—kidney cancer	3.25e-05	0.000265	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CYP1A1—kidney cancer	3.24e-05	0.000264	CbGpPWpGaD
Bumetanide—CA4—Metabolism—BCHE—kidney cancer	3.23e-05	0.000263	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SLC2A1—kidney cancer	3.23e-05	0.000263	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GSTP1—kidney cancer	3.22e-05	0.000262	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GSTM1—kidney cancer	3.2e-05	0.00026	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GSTM1—kidney cancer	3.2e-05	0.00026	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SLC5A5—kidney cancer	3.19e-05	0.000259	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.19e-05	0.000259	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—MAPK1—kidney cancer	3.16e-05	0.000257	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.13e-05	0.000255	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PGK1—kidney cancer	3.12e-05	0.000254	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC5A3—kidney cancer	3.12e-05	0.000254	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	3.12e-05	0.000254	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	3.1e-05	0.000252	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AMER1—kidney cancer	3.1e-05	0.000252	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SLC2A1—kidney cancer	3.08e-05	0.000251	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—LDHB—kidney cancer	3.06e-05	0.000249	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.06e-05	0.000249	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ABCB1—kidney cancer	3.05e-05	0.000248	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PDHB—kidney cancer	3.05e-05	0.000248	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL2—kidney cancer	3.04e-05	0.000247	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CYP1A1—kidney cancer	3.03e-05	0.000246	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CYP1A1—kidney cancer	3.03e-05	0.000246	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.02e-05	0.000245	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTT1—kidney cancer	2.99e-05	0.000244	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ACHE—kidney cancer	2.99e-05	0.000244	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	2.96e-05	0.000241	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GSTM1—kidney cancer	2.96e-05	0.000241	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.94e-05	0.000239	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	2.88e-05	0.000234	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CCBL1—kidney cancer	2.87e-05	0.000233	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SCARB1—kidney cancer	2.83e-05	0.000231	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTGS1—kidney cancer	2.81e-05	0.000228	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CYP1A1—kidney cancer	2.81e-05	0.000228	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PSMD7—kidney cancer	2.75e-05	0.000224	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.73e-05	0.000222	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GSTP1—kidney cancer	2.69e-05	0.000219	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.68e-05	0.000218	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—TP53—kidney cancer	2.66e-05	0.000216	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CA9—kidney cancer	2.65e-05	0.000216	CbGpPWpGaD
Bumetanide—CA9—Metabolism—BCHE—kidney cancer	2.61e-05	0.000212	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GPC3—kidney cancer	2.59e-05	0.000211	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.59e-05	0.000211	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.59e-05	0.000211	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SLC5A5—kidney cancer	2.58e-05	0.00021	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GSTP1—kidney cancer	2.57e-05	0.000209	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ABCB1—kidney cancer	2.55e-05	0.000207	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.52e-05	0.000205	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SLC2A1—kidney cancer	2.49e-05	0.000202	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GLIPR1—kidney cancer	2.49e-05	0.000202	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPAT—kidney cancer	2.49e-05	0.000202	CbGpPWpGaD
Bumetanide—CA14—Metabolism—POMC—kidney cancer	2.48e-05	0.000202	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GSTM1—kidney cancer	2.47e-05	0.000201	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.45e-05	0.0002	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	2.44e-05	0.000199	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ABCB1—kidney cancer	2.43e-05	0.000198	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.43e-05	0.000198	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—POMC—kidney cancer	2.42e-05	0.000197	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ST3GAL2—kidney cancer	2.4e-05	0.000195	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MYC—kidney cancer	2.37e-05	0.000193	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GSTM1—kidney cancer	2.36e-05	0.000192	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP1A1—kidney cancer	2.35e-05	0.000191	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	2.32e-05	0.000189	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—FH—kidney cancer	2.31e-05	0.000188	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APRT—kidney cancer	2.31e-05	0.000188	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.3e-05	0.000187	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.28e-05	0.000185	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—POMC—kidney cancer	2.26e-05	0.000184	CbGpPWpGaD
Bumetanide—CA7—Metabolism—POMC—kidney cancer	2.26e-05	0.000184	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.26e-05	0.000184	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CRABP1—kidney cancer	2.25e-05	0.000183	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC5A3—kidney cancer	2.25e-05	0.000183	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PGK1—kidney cancer	2.25e-05	0.000183	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP1A1—kidney cancer	2.24e-05	0.000182	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—RAF1—kidney cancer	2.24e-05	0.000182	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SFRP2—kidney cancer	2.21e-05	0.000179	CbGpPWpGaD
Bumetanide—PTGS2—Disease—LDHB—kidney cancer	2.21e-05	0.000179	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GPC3—kidney cancer	2.17e-05	0.000177	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CA2—kidney cancer	2.11e-05	0.000172	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.11e-05	0.000172	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ITPR2—kidney cancer	2.1e-05	0.000171	CbGpPWpGaD
Bumetanide—CA12—Metabolism—POMC—kidney cancer	2.09e-05	0.00017	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTP1—kidney cancer	2.08e-05	0.000169	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALAD—kidney cancer	2.06e-05	0.000167	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TCEB1—kidney cancer	2.06e-05	0.000167	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TCEB2—kidney cancer	2.06e-05	0.000167	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—RAF1—kidney cancer	2.03e-05	0.000165	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.01e-05	0.000164	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ST3GAL2—kidney cancer	2.01e-05	0.000163	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.01e-05	0.000163	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.99e-05	0.000162	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTGS2—kidney cancer	1.98e-05	0.000161	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ABCB1—kidney cancer	1.96e-05	0.00016	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALDH1A1—kidney cancer	1.96e-05	0.00016	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TP53—kidney cancer	1.95e-05	0.000159	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.94e-05	0.000158	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.93e-05	0.000157	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTGS2—kidney cancer	1.93e-05	0.000157	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.93e-05	0.000157	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTT1—kidney cancer	1.91e-05	0.000155	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ACHE—kidney cancer	1.91e-05	0.000155	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTM1—kidney cancer	1.91e-05	0.000155	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PGK1—kidney cancer	1.88e-05	0.000153	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC5A3—kidney cancer	1.88e-05	0.000153	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—LDHB—kidney cancer	1.85e-05	0.00015	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SCARB1—kidney cancer	1.81e-05	0.000147	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP1A1—kidney cancer	1.81e-05	0.000147	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTGS2—kidney cancer	1.8e-05	0.000147	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTGS2—kidney cancer	1.8e-05	0.000147	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTGS1—kidney cancer	1.79e-05	0.000146	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PSMD7—kidney cancer	1.76e-05	0.000143	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.76e-05	0.000143	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—POMC—kidney cancer	1.75e-05	0.000142	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTEN—kidney cancer	1.73e-05	0.00014	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—RAF1—kidney cancer	1.71e-05	0.000139	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTEN—kidney cancer	1.68e-05	0.000137	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPL14—kidney cancer	1.67e-05	0.000136	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTGS2—kidney cancer	1.67e-05	0.000136	CbGpPWpGaD
Bumetanide—CA4—Metabolism—POMC—kidney cancer	1.67e-05	0.000136	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—BCHE—kidney cancer	1.67e-05	0.000135	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.66e-05	0.000135	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC5A5—kidney cancer	1.64e-05	0.000134	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.62e-05	0.000131	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CA9—kidney cancer	1.6e-05	0.00013	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC2A1—kidney cancer	1.59e-05	0.000129	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.58e-05	0.000129	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTEN—kidney cancer	1.57e-05	0.000128	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTEN—kidney cancer	1.57e-05	0.000128	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.57e-05	0.000127	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.54e-05	0.000125	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.51e-05	0.000123	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ITPR2—kidney cancer	1.51e-05	0.000123	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.49e-05	0.000121	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTEN—kidney cancer	1.46e-05	0.000118	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.42e-05	0.000116	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTGS2—kidney cancer	1.4e-05	0.000113	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.37e-05	0.000112	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CRABP1—kidney cancer	1.36e-05	0.000111	CbGpPWpGaD
Bumetanide—CA9—Metabolism—POMC—kidney cancer	1.35e-05	0.00011	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.34e-05	0.000109	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTGS2—kidney cancer	1.33e-05	0.000108	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.33e-05	0.000108	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTP1—kidney cancer	1.32e-05	0.000108	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PSMD7—kidney cancer	1.27e-05	0.000103	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ITPR2—kidney cancer	1.27e-05	0.000103	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ABCB1—kidney cancer	1.25e-05	0.000102	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PIK3CA—kidney cancer	1.22e-05	9.91e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTM1—kidney cancer	1.22e-05	9.9e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTEN—kidney cancer	1.22e-05	9.9e-05	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PIK3CA—kidney cancer	1.19e-05	9.66e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.17e-05	9.49e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTEN—kidney cancer	1.16e-05	9.44e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ACHE—kidney cancer	1.15e-05	9.39e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTT1—kidney cancer	1.15e-05	9.39e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP1A1—kidney cancer	1.15e-05	9.39e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC2A1—kidney cancer	1.15e-05	9.32e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—JUNB—kidney cancer	1.14e-05	9.25e-05	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3CA—kidney cancer	1.11e-05	9.02e-05	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3CA—kidney cancer	1.11e-05	9.02e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SCARB1—kidney cancer	1.09e-05	8.89e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PTGS1—kidney cancer	1.08e-05	8.8e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTGS2—kidney cancer	1.08e-05	8.75e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PSMD7—kidney cancer	1.06e-05	8.63e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CA—kidney cancer	1.03e-05	8.35e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—BCHE—kidney cancer	1.01e-05	8.18e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC5A5—kidney cancer	9.93e-06	8.08e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC2A1—kidney cancer	9.59e-06	7.8e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.48e-06	7.71e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTEN—kidney cancer	9.38e-06	7.63e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CDKN2B—kidney cancer	9.26e-06	7.53e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—POMC—kidney cancer	8.61e-06	7e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CA—kidney cancer	8.58e-06	6.98e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CA—kidney cancer	8.19e-06	6.66e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.12e-06	6.6e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTP1—kidney cancer	8e-06	6.51e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCB1—kidney cancer	7.57e-06	6.16e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HIF1A—kidney cancer	7.4e-06	6.02e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TSC2—kidney cancer	7.38e-06	6e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTM1—kidney cancer	7.35e-06	5.98e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP1A1—kidney cancer	6.97e-06	5.67e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTGS2—kidney cancer	6.86e-06	5.58e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CA—kidney cancer	6.62e-06	5.38e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APC—kidney cancer	6.52e-06	5.3e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KIT—kidney cancer	6.52e-06	5.3e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—BRAF—kidney cancer	6.13e-06	4.98e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTEN—kidney cancer	5.99e-06	4.87e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.73e-06	4.66e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—POMC—kidney cancer	5.2e-06	4.23e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RAF1—kidney cancer	5.12e-06	4.16e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ERBB2—kidney cancer	5.06e-06	4.12e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MTOR—kidney cancer	5e-06	4.06e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD4—kidney cancer	4.99e-06	4.06e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CDKN1B—kidney cancer	4.69e-06	3.81e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CTNNB1—kidney cancer	4.43e-06	3.6e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PTEN—kidney cancer	4.32e-06	3.51e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CA—kidney cancer	4.22e-06	3.44e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MAPK3—kidney cancer	3.69e-06	3e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PTEN—kidney cancer	3.62e-06	2.94e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MYC—kidney cancer	3.59e-06	2.92e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MAPK1—kidney cancer	3.51e-06	2.85e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KRAS—kidney cancer	3.31e-06	2.7e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3CA—kidney cancer	3.05e-06	2.48e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CA—kidney cancer	2.55e-06	2.07e-05	CbGpPWpGaD
